Accelerating Advanced Stem Cell Research
Scaling up Production to Reduce the Price
Advanced stem cell treatments have the potential to transform health care as we know it. Despite this, there is a global shortage of stem cells produced in compliance with Good Manufacturing Practice (GMP) standards. To bridge this gap, Cellcolabs was established in 2021, aiming to meet the demand for high-quality, GMP-compliant stem cells in the healthcare sector.
Based on 25 Years of Experience
Cellcolabs is a biotech company specialising in Industrial GMP production of high-quality Mesenchymal Stem Cells. The company was founded on the research conducted by Professor Katarina Le Blanc and co-founded by Takura and Norrsken. For two decades, Katarina's team at the Karolinska Institute have been dedicated to advancing stem cell research. Cellcolabs' mission is to leverage this expertise to provide high-quality stem cells on a larger scale.
What are MSCs?
Mesenchymal Stem Cells (MSCs) are adult multipotent stem cells capable of self-renewal and differentiating into multiple cell types. With their anti-inflammatory, immunomodulatory and regenerative properties, they could have the potential to revolutionise the treatment of many severe and incurable diseases.
MSCs help restore old and damaged cells via their tissue regenerative properties. They also reduce inflammation by regulating the immune response. Since their discovery in the 1960s, they have been intensely studied by researchers in laboratories and clinical trials.
Order Cells
Our production facility in in Stockholm, Sweden specialises in large-scale GMP production of bone marrow-derived MSCs for research and therapeutic applications. If interested in ordering our MSCs for research use, please enquire below.
Donate Cells
Advanced cell therapies have the potential to transform healthcare as we know it. But we need your help to do it. Donate cells and be a part of the stem cell revolution.
Looking for Treatments?
Cellcolabs does not provide treatments. However, we can provide updates on how and when it is possible to join clinical trials using our MSCs.